Abstract
Major histocompatibility complex (MHC) class I and II are glycoproteins that can present antigenic peptides at the cell surface for recognition and activation of circulating T lymphocytes. Here, the importance of the modification of protein antigens by glycans on cellular uptake, proteolytic processing, presentation by MHC and subsequent T-cell priming is reviewed. Antigen glycosylation is important for a number of diseases and vaccine design. All of the key proteins involved in antigen recognition and the orchestration of downstream effector functions are glycosylated. The influence of protein glycosylation on immune function and disease is covered.
| Original language | English |
|---|---|
| Pages (from-to) | 776-84 |
| Number of pages | 9 |
| Journal | Nature Chemical Biology |
| Volume | 9 |
| Issue number | 12 |
| DOIs | |
| Publication status | Published - Dec 2013 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Adaptive Immunity
- Antigens
- Glycoproteins
- Glycosylation
- Major Histocompatibility Complex
- Vaccines
Fingerprint
Dive into the research topics of 'Adaptive immune activation: glycosylation does matter'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver